PROTECT-Study: Prospective Research on Optimizing Atropine Concentration Escalation for Children's Myopia Prevention

NCT07449247 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

233

Enrollment

OTHER

Sponsor class

Conditions

Pre-myopia

Interventions

DRUG: 0.01% Atropine

Sponsor

Tianjin Medical University Eye Hospital